Neurocrine Biosciences, Inc.
NBIX
$155.80
$5.213.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.50% | 37.57% | -9.22% | -6.09% | -22.06% |
| Total Receivables | 48.86% | 43.35% | 51.32% | 27.23% | 14.49% |
| Inventory | 9.14% | 20.21% | 51.31% | 33.88% | 58.87% |
| Prepaid Expenses | -- | 251.96% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -47.61% | 82.08% | -43.96% | 0.42% | 18.71% |
| Total Current Assets | 48.73% | 46.27% | 15.02% | 4.74% | -8.95% |
|
|
|||||
| Total Current Assets | 48.73% | 46.27% | 15.02% | 4.74% | -8.95% |
| Net Property, Plant & Equipment | -8.69% | -7.91% | 67.86% | 70.26% | 70.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 3.48% | 11.04% | 6.12% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.60% | -29.37% | -23.75% | 16.99% | 19.95% |
| Total Assets | 33.04% | 24.55% | 20.67% | 17.69% | 6.20% |
|
|
|||||
| Total Accounts Payable | 9.09% | 5.01% | 25.29% | -2.43% | 26.00% |
| Total Accrued Expenses | 37.32% | 42.56% | 56.36% | 42.94% | 11.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.66% | -- | 47.41% | 43.22% | -71.10% |
| Total Finance Division Other Current Liabilities | 582.91% | 44.56% | 9.09% | 591.30% | -83.10% |
| Total Other Current Liabilities | 582.91% | 44.56% | 9.09% | 591.30% | -83.10% |
| Total Current Liabilities | 59.06% | 46.43% | 48.48% | 37.09% | -26.65% |
|
|
|||||
| Total Current Liabilities | 59.06% | 46.43% | 48.48% | 37.09% | -26.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.23% | -8.75% | 70.41% | 71.39% | 76.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 43.67% | 32.19% | 44.96% | 48.90% | 50.71% |
| Total Liabilities | 30.10% | 22.09% | 54.65% | 50.23% | 6.05% |
|
|
|||||
| Common Stock & APIC | 11.27% | 9.30% | 2.79% | 1.64% | 1.42% |
| Retained Earnings | 11,224.53% | 1,433.22% | 262.52% | 273.51% | 95.34% |
| Treasury Stock & Other | -95.56% | 125.86% | -8.97% | 400.00% | 172.73% |
| Total Common Equity | 34.38% | 25.62% | 10.47% | 7.38% | 6.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.38% | 25.62% | 10.47% | 7.38% | 6.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 34.38% | 25.62% | 10.47% | 7.38% | 6.27% |
|
|
|||||